RxDoctor Payments DataLook up a doctor →

Ariel Palanca, MD

Orthopaedic Surgery · Stanford, CANPI 1629203971

Payments from drug & device makers

$633,375in general payments, 2019–2025

Across 782 payments — averaging $809.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medshape, Inc.$227K
  • Trilliant Surgical LLC.$180K
  • Stryker$140K
  • Encore Medical, LP$22K
  • Acumed LLC$16K
  • Novastep Inc.$10K
  • plus $38K from 22 others

What the payments were for

  • Royalty or licence$36,0896%
  • Consulting fees$466,73075%
  • Speaking & faculty fees$10,8502%
  • Travel & lodging$84,98314%
  • Food & beverage$25,6564%
  • Education$5260%
  • Other$2410%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$633,375 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$206,441
Medicare patients
404
Services billed
4,764

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin171$655
Oxycodone Hcl101$515
Ibuprofen11$78
Tramadol Hcl17$53

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →